Citation Impact
Citing Papers
Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture
2009 Standout
Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
2013 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
2000 StandoutNobel
Embryo Implantation
2000 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
2005 Standout
Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures
2001
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
2005
Peyronie's Disease
2007
Macrophages in immunoregulation and therapeutics
2023 Standout
The Thrombospondins
2011 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Group IV Cytosolic Phospholipase A2(Pla2) Function:Insights from the Knockout Mouse
2002
The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test
1994
Polymer conjugates as anticancer nanomedicines
2006 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Characterization of Prostaglandin H Synthase 2 Deficient Mice and Implications for Mechanisms of NSAID Action
1997 StandoutNobel
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
Safety assessment of esters of p-hydroxybenzoic acid (parabens)
2005 Standout
Collagenase in the treatment of Dupuytren's disease: An in vitro study
1996
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 Standout
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
The PPARα–leukotriene B4 pathway to inflammation control
1996 Nature
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications
2003 Standout
Acute and chronic systemic chromium toxicity
1989
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2–deficient mice
2002
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
The Mechanisms of Action of PPARs
2002 Standout
The Use of Collagenase in the Treatment of Peyronie’s Disease
1985
Phase 2b Study of the Clinical Efficacy and Safety of Collagenase Clostridium Histolyticum in Patients With Peyronie Disease
2012
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
2005 Standout
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
2000 StandoutNobel
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
The LLNA: A Brief Review of Recent Advances and Limitations
2011
The Use of Intralesional Clostridial Collagenase Injection Therapy for Peyronie's Disease: A Prospective, Single-Center, Non-Placebo-Controlled Study
2008
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
A critical role of placental growth factor in the induction of inflammation and edema formation
2002
Cyclooxygenase in biology and disease
1998 Standout
Potential Health Effects Associated with Dermal Exposure to Occupational Chemicals
2014 Standout
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Prostaglandins and Inflammation
2011 Standout
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Chromium occurrence in the environment and methods of its speciation
2000 Standout
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Works of Robert D. Walsh being referenced
Collagenase for Peyronie's disease experimental studies
1982
Development and validation of an alternative dermal sensitization test: The mouse ear swelling test (MEST)
1986